Validation of an automated viable cell counting assay for GMP manufacturing of human induced pluripotent stem cells-Reference-Cited by-同舟云学术

Validation of an automated viable cell counting assay for GMP manufacturing of human induced pluripotent stem cells

Published:2023-07 Issue: Volume:196 Page:108953
ISSN:1369-703X
Container-title:Biochemical Engineering Journal
language:en
Short-container-title:Biochemical Engineering Journal

Author:

Peli Valeria^ORCID,Barilani Mario,Rivera-Ordaz Araceli^ORCID,Manzini Paolo^ORCID,Rusconi Francesco^ORCID,Lavazza Cristiana^ORCID,Cimoni Silvia,Lazzari Lorenza^ORCID

Publisher

Elsevier BV

Subject

Biomedical Engineering,Environmental Engineering,Bioengineering,Biotechnology

Reference23 articles.

1. The progression of regenerative medicine and its impact on therapy translation;Jacques;Clin. Transl. Sci.,2020

2. Regenerative medicine: clinical applications and future perspectives;Colombo;J. Microsc. Ultrastruct.,2017

3. Anthony Lodge, G.D. Manufacturing Process Development of ATMPs within a Regulatory Framework for EU Clinical Trial & Marketing Authorisation Applications Available online: https://insights.bio/immuno-oncology-insights/journal/article/467/manufacturing-process-development-of-atmps-within-a-regulatory-framework-for-eu-clinical-trial-marketing-authorisation-applications (accessed on 7 July 2022).

4. Induction of pluripotent stem cells from fibroblast cultures;Takahashi;Nat. Protoc.,2007

5. A manually curated database on clinical studies involving cell products derived from human pluripotent stem cells;Kobold;Stem Cell Rep.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive analysis of viability assessment methods for Giardia lamblia and Trichomonas vaginalis: a systematic review;2023-12-27